Catherine Alix-Panabières, PhD
Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB, Hôpital Saint-Eloi - CHRU Montpellier, France
Emmanuel Antonarakis, MD
Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA
Ryan Corcoran, MD
Assoc. Professor, Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts
Richard J. Cote, M.D. FRCPath, FCAP
Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, Barnes-Jewish Hospital, Washinghton University in St Louis, St Louis, USA
Massimo Cristofanilli, MD, FACP
Chief, Breast Medical Oncology
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine
Co-Leader, Meyer Cancer Center Management Team
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine
Co-Leader, Meyer Cancer Center Management Team
Johann de Bono,
Professor, Head of the Division of Clinical Studies, The Institute for Cancer Research, (ICR) and Royal Marsden, London, UK
Caroline Dive, PhD
Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK
Daniel Haber, MD, PhD
Kurt J. Isselbacher Professor of Oncology, Medicine, Harvard Medical School, Director, MGH Cancer Center, Massachusetts General Hospital, Boston, USA
Ellen Heitzer, PhD
Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria
Wolfgang Janni, MD PhD
Medical Director of the Gynaecological University Hospital Ulm, University of Ulm, Germany
Pashtoon Murtaza Kasi, M.D., M.S.
Οncologist and researcher at Weill Cornell Medicine and New York-Presbyterian Hospital
Sabine Kasimir-Bauer, PhD
Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany
Peter Kuhn, PhD
Dean’s Professor of Biological
Sciences and Professor of Medicine, Biomedical Engineering, Aerospace &
Mechanical Engineering, and Urology, USC
Michelson CSI-Cancer, Los Angeles, California, USA
Evi Lianidou, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece
Mike Makrigiorgos, PhD
Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Stuart S. Martin, PhD
Professor of Translational Cancer Research, University of Maryland School of Medicine, USA
Klaus Pantel, MD, PhD
Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Nicholas Papadopoulos, PhD
Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
Jean-Yves Pierga, MD, PhD
Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France
Amanda Psyrri, MD, PhD
Professor, University of Athens Medical School, Attikon University Hospital, Athens, Greece
Chamindie Punyadeera, MD
Griffith University, Griffith Institute for Drug Discovery (GRIDD) and Menzies Health Institute Queensland (MIHQ), Saliva and Liquid Biopsy Translational Laboratory, Queensland, Australia
Christian Rolfo, MD, PhD, MBA, Dr.hc.
Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, USA
Gabriella Sozzi, PhD
Tumour Genomics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Nikolas Stoecklein, MD
Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany
Leon Terstappen, MD, PhD
Professor, Faculty of Science and Technology, TechMed Centre, Department of Medical Cell BioPhysics, University of Twente, the Netherlands
Andreas Trumpp, PhD
Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany